- ►ahajournals.org SZ Duan, MG Usher, RM Mortensen - Circulation Research, 2008 - Am Heart Assoc Peroxisome proliferator-activated receptor (PPAR)- is a nuclear receptor and
transcription factor in the steroid superfamily. PPAR- agonists, the
thiazolidinediones, are clinically used to treat type 2 diabetes. In ... Cited by 44 - Related articles - All 5 versions
DF Gao, XL Niu, GH Hao, N Peng, J Wei, N … - Biochemical pharmacology, 2007 - Elsevier Angiotensin (Ang) II plays a pivotal role in vascular fibrosis, which leads to
serious complications in hypertension and diabetes. Connective tissue growth
factor (CTGF) is a potent profibrotic factor implicated in the Ang ... Cited by 22 - Related articles - All 4 versions
MH Jarrar, A Baranova - Journal of cellular and molecular medicine, 2007 - interscience.wiley.com The thiazolidinediones (TZDs) are a class of synthetic antidiabetic drugs
exerting its action primarily upon acti-vation of the peroxisome
proliferator-activated receptor-γ (PPARγ). Given the widespread incidence ... Cited by 15 - Related articles - BL Direct - All 2 versions
XJ Wang, Z Dong, XH Zhong, RZ Shi, SH … - Biochemical and Biophysical Research …, 2008 - Elsevier Angiogenesis is essential for transplantation of mesenchymal stem cells (MSCs).
Vascular endothelial growth factor (VEGF) is one of the most potent angiogenic
factors identified to date. Elevated VEGF levels in MSCs correlate with the ... Cited by 15 - Related articles - All 4 versions
- ►aspetjournals.org E Ruiz, S Redondo, A Gordillo-Moscoso, T … - Journal of Pharmacology and Experimental …, 2007 - ASPET Alterations in vascular wall remodeling are a typical complication in type 2
diabetes mellitus due to an imbalance between cell proliferation and apoptosis.
In this context, we have previously shown that vascular smooth muscle cells ... Cited by 9 - Related articles - All 3 versions
S Redondo, CG Santos-Gallego, T Tejerina - Cytokine and Growth Factor Reviews, 2007 - Elsevier Transforming growth factor beta-1 (TGF-β1) plays a key role in cardiovascular
disease by a process which allows the loss of its protective properties. The
first therapeutic attempt to restore its function by selectively designed ... Cited by 9 - Related articles - All 16 versions
LW Zhang, S Piao, MJ Choi, HY Shin, HR Jin … - J Sex Med, 2008 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 8 - Related articles - All 5 versions
JJ Bright, S Kanakasabai, W Chearwae, S … - PPAR research, 2008 - downloads.hindawi.com Hindawi Publishing Corporation PPAR Research Volume 2008, Article ID 658520, 12
pages doi:10.1155/2008/658520 ... PPAR Regulation of Inflammatory Signaling in
CNS Diseases ... John J. Bright, 1, 2 Saravanan Kanakasabai, 1 Wanida ... Cited by 7 - Related articles - View as HTML - All 15 versions
M Decker, H Hofflich, AN Elias - Diabetes, Obesity and Metabolism, 2008 - pt.wkhealth.com The thiazolidinediones (TZDs) or glitazones are pharmaceutical agents that have
profound effects on energy expenditure and conservation. They also exert
significant anti-inflammatory effects and influence cell proliferation and ... Cited by 7 - Related articles - All 5 versions
